Pneumonia News and Research

Latest Pneumonia News and Research

A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

New research highlights principal host factors that may explain the immune responses to SARS-CoV-2 and its variants in the context of infection susceptibility, disease severity, and previous immunity.

28 Jan 2022

γ’ fibrinogen as a disease progression marker for COVID-19

Levels of the inflammatory biomarker gamma prime fibrinogen (γ' Fbg) varies according to severity in COVID-19 patients.

28 Jan 2022

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

Researchers investigate the possible efficacy of IFN-λ in the context of SARS-CoV-2 infection in mice.

28 Jan 2022

Pulse oximeters give false readings in a group of patients with COVID-19

The severity of COVID-19 pneumonia can be difficult to assess in people from different ethnic groups, due to inaccurate readings from a device that measures the level of oxygen in the blood of patients.

28 Jan 2022

Early-stage alveolar epithelial cell necrosis linked to COVID-19-induced acute respiratory distress syndrome

A new study analyzed whether alveolar epithelial cell necrosis at an early stage SARS-CoV-2 infection and subsequent releases of damage-associated molecular patterns could aggravate COVID-19-associated acute respiratory distress syndrome.

27 Jan 2022

Effects of multi-nutrient supplementation on COVID-19 severity in elderly patients

In a new study, researchers analyzed the effects of multi-nutrient supplementation on SARS-CoV-2 vaccine efficacy and the overall improvement of respiratory and muscle function in elderly COVID-19 patients.

27 Jan 2022

Targeting SARS-CoV-2 M protein may help ease severity of COVID-19

A new study, published on the medRxiv preprint server, focused on the production of human CD4+ T cell lines (TCLs), reactive to either S or M protein, and analyzed if the S and M structural proteins had intrinsic differences in driving antigen-specific CD4+ T cell responses.

27 Jan 2022

Study demonstrates differential alternative splicing in betacoronaviruses

A new study investigates whether the proportion of ribosomal genes displaying differential gene expression and differential alternative splicing differed between three betacoronaviruses and six other viruses and bacteria.

26 Jan 2022

Understanding immune responses to SARS-CoV-2 infections in children

A study published in the journal Immunity analyzed the varied manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children.

26 Jan 2022

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

In a new study, exhaled aerosols were compared between infected SARS-CoV-2 patients and healthy controls for the first time. A preprint version of this study, which is yet to undergo peer review, is available on the medRxiv* server.

24 Jan 2022

Exploring loss of Y chromosome in white blood cells as a risk-factor of life-threatening COVID-19 in men

Researchers published a study exploring the possibilities of predisposing men for a life-threatening disease course of COVID-19.

24 Jan 2022

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Researchers have investigated the pathology and inflammatory response to the Delta variant in mice.

24 Jan 2022

Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

In a new study, scientists focused on the SARS-CoV-2 Beta variant and used computational methods to design and develop effective glycoprotein multi-epitope subunit vaccine candidates, based on the old and the new Beta virus strains.

20 Jan 2022

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.

20 Jan 2022

Pioneering AI technology can accurately detect Covid-19 in a few minutes

Pioneering Artificial Intelligence (AI) technology, developed by experts at University of the West of Scotland, is capable of accurately diagnosing Covid-19 in just a few minutes.

19 Jan 2022

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

One viral protein could provide information to deter pneumonia causing the body's exaggerated inflammatory response to respiratory viruses, including the virus that causes COVID-19.

18 Jan 2022

Research shows fewer deaths related to COVID-19 in Cape Town during fourth wave

Researchers observe changes in COVID-19-related deaths during the fourth wave of the COVID-19 pandemic in South Africa.

16 Jan 2022

Exploring the relationship between stem cells and COVID-19

Though COVID-19-related stem cell clinical research is still in its infancy, stem cell treatment offers extensive clinical application possibilities and a far-reaching relevance thanks to ongoing exploration of stem cell clinical research and data mining.

14 Jan 2022

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Researchers conducted a detailed epitope mapping of Np and developed an experimental double antigen-based ELISA.

13 Jan 2022

Plasma SARS-CoV-2 viral RNA as a valuable biomarker for SARS-CoV-2 infection in the lungs

Researchers recently evaluated respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA (vRNA) levels in longitudinal samples collected simultaneously from mechanically ventilated coronavirus disease 2019 (COVID-19) patients and analyzed their connections and relationships with clinical outcomes.

13 Jan 2022

Pneumonia News and Research

Latest Pneumonia News and Research

A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

γ’ fibrinogen as a disease progression marker for COVID-19

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

Pulse oximeters give false readings in a group of patients with COVID-19

Early-stage alveolar epithelial cell necrosis linked to COVID-19-induced acute respiratory distress syndrome

Effects of multi-nutrient supplementation on COVID-19 severity in elderly patients

Targeting SARS-CoV-2 M protein may help ease severity of COVID-19

Study demonstrates differential alternative splicing in betacoronaviruses

Understanding immune responses to SARS-CoV-2 infections in children

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

Exploring loss of Y chromosome in white blood cells as a risk-factor of life-threatening COVID-19 in men

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

Pioneering AI technology can accurately detect Covid-19 in a few minutes

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

Research shows fewer deaths related to COVID-19 in Cape Town during fourth wave

Exploring the relationship between stem cells and COVID-19

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Plasma SARS-CoV-2 viral RNA as a valuable biomarker for SARS-CoV-2 infection in the lungs

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pneumonia News and Research

Latest Pneumonia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in